Technology
Go Back
PreSize® Neurovascular
Technology
About
Go Back
News
The Team
Our Journey
About
Clinical Evidence
Go Back
Partners
Clinical Trials
Publications
Clinical Evidence
Log In
Contact Us
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Deny
Accept
Privacy Preferences
Essential cookies
Required
Marketing cookies
Essential
Personalization cookies
Essential
Analytics cookies
Essential
Reject all cookies
Allow all cookies
Save preferences
Press Release
CEO Dr Katerina Spranger awarded the Princess Royal Silver Medal by the Academy of Engineering
Read more
In The Press
AI-driven technology could transform aneurysm treatment
Read more
Press Release
PreSize® trial receives ethics and compliance approval
Read more
Press Release
Oxford Heartbeat secures highly sought-after Innovate UK award
Read more
In The Press
The Telegraph: From Musk to Bezos: the remarkable rise of the executive engineer
Read more
Press Release
PreSize® Neurovascular is launched in the NHS
Read more
Press Release
Interview with Enterprising Oxford
Read more
Press Release
October 19, 2020
Interview with Enterprising Oxford
An illuminating conversation with our CEO Katerina in the October edition of Enterprising Oxford's Entrepreneur Uncovered series...
Press Release
September 8, 2020
Oxford Heartbeat wins AI in Health and Care Award
Oxford Heartbeat wins mandate to improve brain stenting with prestigious NHSX AI in Health and Care Award...
Press Release
July 1, 2020
Interview with the Royal Academy of Engineering
Spotlight Series with the Royal Academy of Engineering's Enterprise Hub: Excerpts from an interview with our CEO and founder Katerina...
Press Release
May 27, 2020
Feature on CE marking with DigitalHealth.London
DigitalHealth.London's SME of the Week: Oxford Heartbeat shares some useful tips on the process of acquiring CE marking...
Press Release
March 16, 2020
Oxford Heartbeat is awarded CE marking
Having been awarded a CE mark, Oxford Heartbeat's life-saving technology is now available for use across the EU...
Previous
Load more
Jan 20, 2022
PreSize® trial receives ethics and compliance approval
Oxford Heartbeat secures ethics and HRA approval to commence clinical trials...
Get in touch to find out more about PreSize®
Contact us